Merit Medical Systems, Inc. (NASDAQ:MMSI) Given Average Rating of "Moderate Buy" by Analysts

Key Points

• Analyst consensus: Ten analysts give Merit Medical an average rating of "Moderate Buy" (seven buy, three hold) with a one‑year average price target of $101.25.
• Recent results: Merit beat expectations with Q EPS $1.04 vs. $0.96 consensus and revenue $393.94M (up 10.9% YoY), and set FY2026 guidance of $4.01–$4.15 EPS while analysts on average forecast 3.37 for the current year.
• Stock and ownership: Shares trade around $67.70 (12‑month high $106.11), the company has a market cap of about $4.0B and a P/E of ~31.9, and institutional investors hold roughly 99.7% of the stock.

Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the ten analysts that are currently covering the company, Marketbeat.com reports. Three analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average 1-year price target among brokerages that have issued a report on the stock in the last year is $101.25.

A number of research analysts have weighed in on the company. Canaccord Genuity Group raised their price objective on Merit Medical Systems from $93.00 to $99.00 and gave the company a "buy" rating in a report on Wednesday, December 17th. BTIG Research assumed coverage on shares of Merit Medical Systems in a report on Friday, February 6th. They set a "buy" rating and a $107.00 target price for the company. Piper Sandler reduced their target price on shares of Merit Medical Systems from $113.00 to $106.00 and set an "overweight" rating for the company in a research report on Wednesday, February 18th. Wall Street Zen downgraded shares of Merit Medical Systems from a "strong-buy" rating to a "buy" rating in a research note on Sunday. Finally, Needham & Company LLC restated a "buy" rating and set a $101.00 price target on shares of Merit Medical Systems in a research report on Wednesday.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Los Angeles Capital Management LLC acquired a new stake in shares of Merit Medical Systems in the fourth quarter valued at approximately $25,000. Maseco LLP purchased a new position in Merit Medical Systems during the fourth quarter worth approximately $26,000. Salomon & Ludwin LLC acquired a new position in Merit Medical Systems during the third quarter worth $37,000. Torren Management LLC purchased a new stake in Merit Medical Systems in the 4th quarter valued at $38,000. Finally, Covestor Ltd grew its holdings in Merit Medical Systems by 252.6% in the 4th quarter. Covestor Ltd now owns 469 shares of the medical instruments supplier's stock valued at $41,000 after buying an additional 336 shares in the last quarter. 99.66% of the stock is currently owned by institutional investors and hedge funds.

Merit Medical Systems Price Performance

NASDAQ:MMSI opened at $67.70 on Friday. The stock has a 50 day moving average of $75.42 and a two-hundred day moving average of $81.59. Merit Medical Systems has a 12 month low of $66.34 and a 12 month high of $106.11. The firm has a market cap of $4.04 billion, a P/E ratio of 31.93, a price-to-earnings-growth ratio of 1.95 and a beta of 0.64. The company has a current ratio of 4.34, a quick ratio of 2.95 and a debt-to-equity ratio of 0.46.

Merit Medical Systems (NASDAQ:MMSI - Get Free Report) last released its earnings results on Tuesday, February 24th. The medical instruments supplier reported $1.04 earnings per share for the quarter, beating the consensus estimate of $0.96 by $0.08. Merit Medical Systems had a return on equity of 13.82% and a net margin of 8.48%.The business had revenue of $393.94 million for the quarter, compared to the consensus estimate of $390.77 million. During the same quarter last year, the business posted $0.93 earnings per share. The business's quarterly revenue was up 10.9% compared to the same quarter last year. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. On average, analysts expect that Merit Medical Systems will post 3.37 earnings per share for the current fiscal year.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company's product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.